COVID-19-associated mucormycosis, diabetes and steroid therapy: Experience in a single centre in Western Mexico.

Salvador Guzmán-CastroLuis David Chora-HernandezGersain Trujillo-AlonsoIvan Calvo-VillalobosAntonio Sanchez-RangelEdgar Ferrer-AlpuinMiguel Ruiz-JimenezDora E Corzo-Leon

Published in: Mycoses (2021)

Similar to large reports in India and other countries, CAM cases reported in this study were diagnosed in individuals with diabetes, hyperglycaemic status and with history of previous use of corticosteroids. Identifying these individuals at risk can help the early identification of CAM. In addition, strict glycaemic control and avoidance of unnecessary corticosteroid in non-severe COVID-19 cases could help in preventing this complicated fungal infection.

Keyphrases

type diabetes
coronavirus disease
sars cov
cardiovascular disease
glycemic control
early onset
respiratory syndrome coronavirus
stem cells
emergency department
adipose tissue
metabolic syndrome
bone marrow
mesenchymal stem cells
weight loss
cell wall